Search | Bundas24

Kajalpatil Patil added blog Health
2025-06-16 10:08:10 -

Gastrointestinal Stromal Tumor (GIST) Market is driven by targeted therapies
The gastrointestinal stromal tumor (GIST) market encompasses a range of targeted therapies, small-molecule inhibitors, monoclonal antibodies, and companion diagnostics designed to manage and treat GIST, a rare form of soft tissue tumor arising in the digestive tract. Products like imatinib mesylate, sunitinib, and regorafenib offer precision action against aberrant KIT and PDGFRA gene...

0 Comments 0 Shares 655 Views 0 Reviews

Please log in to like, share and comment!
Khushbu Coherent added blog Health
2025-05-26 10:15:30 -

Gastrointestinal Stromal Tumor (GIST) Market is driven by Precision Medicine
The gastrointestinal stromal tumor (GIST) market encompasses innovative targeted therapies, including tyrosine kinase inhibitors (TKIs) such as imatinib, sunitinib, regorafenib, ripretinib, and avapritinib. These products offer significant advantages over traditional chemotherapy by blocking specific oncogenic pathways, reducing off-target toxicity, and improving patient outcomes....

0 Comments 0 Shares 498 Views 0 Reviews

Please log in to like, share and comment!